These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8353764)

  • 1. [Use of the CA 19-9 tumor marker in the diagnosis of pancreatic carcinoma].
    Kausitz J; Lesný P; Belan V
    Bratisl Lek Listy; 1993 Apr; 94(4):201-3. PubMed ID: 8353764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour antigens CA 195 and CA 19-9 in pancreatic juice and serum for the diagnosis of pancreatic carcinoma.
    Hyöty M; Hyöty H; Aaran RK; Airo I; Nordback I
    Eur J Surg; 1992 Mar; 158(3):173-9. PubMed ID: 1356458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The value of endoscopic retrograde cholangiopancreatography in patients with suspected carcinoma of the pancreas and indeterminate computed tomographic results.
    Frick MP; Feinberg SB; Goodale RL
    Surg Gynecol Obstet; 1982 Aug; 155(2):177-82. PubMed ID: 7101106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis.
    Malesci A; Evangelista A; Mariani A; Bersani M; Bonato C; Basilico M; Montorsi M; Beretta E
    Int J Pancreatol; 1988; 3 Suppl 1():S119-23. PubMed ID: 3209865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients.
    Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
    Anticancer Res; 1992; 12(6B):2309-14. PubMed ID: 1295478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The differential diagnosis of chronic pancreatitis and pancreatic cancer].
    Brailski Kh; Mendizova A; Dinkov L; Damianov D; Glavincheva I
    Vutr Boles; 1989; 28(2):54-7. PubMed ID: 2669339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic importance of the tumor marker CA 19-9 in pancreatic cancer].
    Safi F; Büchler M; Schenkluhn B; Beger HG
    Dtsch Med Wochenschr; 1984 Dec; 109(49):1869-73. PubMed ID: 6209082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A comparison of the diagnostic accuracy of ultrasound, computer tomography and ERPC in chronic pancreatitis and carcinoma of the pancreas (author's transl)].
    Gmelin E; Weiss HD; Fuchs HD; Reiser M
    Rofo; 1981 Feb; 134(2):136-41. PubMed ID: 6452353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of early-stage pancreatic neoplasms].
    Ariyama J
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):334-7. PubMed ID: 1607793
    [No Abstract]   [Full Text] [Related]  

  • 10. Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19-9 assessment, US, CT, and CT-guided fine-needle biopsy.
    DelMaschio A; Vanzulli A; Sironi S; Castrucci M; Mellone R; Staudacher C; Carlucci M; Zerbi A; Parolini D; Faravelli A
    Radiology; 1991 Jan; 178(1):95-9. PubMed ID: 1984331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoscopic retrograde cholangio-pancreaticography (ERCP) and computer tomography in the diagnosis of chronic pancreatitis, pseudocysts and carcinoma of the pancreas--a comparison (author's transl)].
    Lammer J; Lepuschütz H; Sager WD; Kratochvil P; Brandstätter G; Zalaudek G
    Rontgenblatter; 1980 Dec; 33(12):602-11. PubMed ID: 7455535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of endoscopic retrograde cholangiopancreatography in cancer of the pancreas].
    Aparcero M; González JA; Navarro I
    G E N; 1988; 42(4):147-51. PubMed ID: 3152667
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor markers in pancreatic cancer. Sensitivity and specificity of CA 19-9.
    Safi F; Roscher R; Beger HG
    Hepatogastroenterology; 1989 Dec; 36(6):419-23. PubMed ID: 2613165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of imaging techniques in the diagnosis of pancreatic diseases].
    Bargon G; Maier W
    Radiologe; 1990 Sep; 30(9):399-407. PubMed ID: 2236550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ca 19-9 in the diagnosis of pancreatic carcinoma].
    Meggiato T; Basso D; Pasquali C; Angonese C; Bellinvia S; Del Favero G; Fabris C; Di Mario F; Plebani M; Pedrazzoli S
    Minerva Med; 1989 May; 80(5):431-4. PubMed ID: 2747969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
    Chen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun; 11(3):229-31. PubMed ID: 2529993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [How much diagnostics in patients with pancreatic cancer?].
    Bosseckert H
    Zentralbl Chir; 2003 May; 128(5):368-74. PubMed ID: 12813633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in nuclear spin tomographic diagnosis of pancreatic tumors].
    Gaa J; Richter A; Trede M; Georgi M
    Dtsch Med Wochenschr; 1998 Jun; 123(24):773-6. PubMed ID: 9672480
    [No Abstract]   [Full Text] [Related]  

  • 19. [Laboratory diagnosis of pancreatitis and pancreatic cancer].
    Degtiareva II; Gaĭsenko AV; Putseva NM
    Vrach Delo; 1989 Jul; (7):42-4. PubMed ID: 2800494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of radioimmunological analysis of CA-19-9 in the blood serum in cancer of the pancreas].
    Putseva NM; Chebotareva ED; Chernyĭ VA; Tashchiev RK
    Klin Khir (1962); 1989; (11):15-7. PubMed ID: 2625847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.